Hydralazine injection Market

Hydralazine injectionis used to treat high blood pressure (hypertension).COVID-19 has erupted in the world, and these drugs are in short supply.

Hydralazine injection Market contains market size and forecasts of Hydralazine injection in global, including the following market information:

Global Hydralazine injection Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global Hydralazine injection Market Sales, 2017-2022, 2023-2028, (K Units)

Global top five Hydralazine injection companies in 2021 (%)

The global Hydralazine injection market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

5 vials / box Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Hydralazine injection include Novartis, Akorn, American Regent, Fresenius Kabi, X-Gen, SteriMax, Troikaa Pharmaceuticals and Zafa Pharmaceutical, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

We surveyed the Hydralazine injection manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Hydralazine injection Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Hydralazine injection Market Segment Percentages, by Type, 2021 (%)

• 5 vials / box
• 10 vials / box

Global Hydralazine injection Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Hydralazine injection Market Segment Percentages, by Application, 2021 (%)

• Hospital
• Clinics
• Recovery Center

Global Hydralazine injection Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Hydralazine injection Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

• Key companies Hydralazine injection revenues in global market, 2017-2022 (Estimated), ($ millions)
• Key companies Hydralazine injection revenues share in global market, 2021 (%)
• Key companies Hydralazine injection sales in global market, 2017-2022 (Estimated), (K Units)
• Key companies Hydralazine injection sales share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Novartis
• Akorn
• American Regent
• Fresenius Kabi
• X-Gen
• SteriMax
• Troikaa Pharmaceuticals
• Zafa Pharmaceutical